It has also been shown that CD99 downregulation leads to the loss of normal morphology in Hodgkin’s disease [80], while the upregulation of CD99 in Hodgkin/Reed–Sternberg cells induces terminal B cell differentiation [84]. The gene discussed is CD99; the disease is Hodgkins lymphoma.